Literature DB >> 20723193

Micro total hip replacement for dogs and cats: surgical technique and outcomes.

William D Liska1.   

Abstract

OBJECTIVE: To describe the surgical technique for the micro total hip replacement (Micro THR) system and report clinical outcomes. STUDY
DESIGN: Prospective study. ANIMALS: Dogs (n=49) and cats (n=8) with coxofemoral arthropathy.
METHODS: Small breed dogs and cats with coxofemoral arthritis were enrolled for Micro THR. Patient data were recorded. Implant positioning and cement mantle quality were evaluated radiographically. Orthopedic examinations and client interviews were used to assess outcome.
RESULTS: Micro THR was performed unilaterally (40 dogs, 8 cats) and staged bilaterally (9 dogs) to resolve pain associated with osteoarthritis or trauma. Mean body weight was 7.2 kg. Postoperative complications included prosthesis luxation (9), cup aseptic loosening (1), and sciatic neurapraxia (1). Mean radiographic follow up was 96.1 weeks; 10 joints were followed for ≥3.0 years. Sixty of the 66 (91%) Micro THRs had excellent outcomes. Two dogs (<2.75 kg) were too small for the prosthesis and 4 dogs with unmanageable luxation had explantation.
CONCLUSIONS: Micro THR is considered a satisfactory procedure for management of small breed dogs and cats with coxofemoral disease unresponsive to medical management. CLINICAL RELEVANCE: Micro THR is a viable option to treat disabling disorders of the hip. More than 170 cat and small dog breeds, and many mixed breeds, could benefit from Micro THR surgery. © Copyright 2010 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723193     DOI: 10.1111/j.1532-950X.2010.00725.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  1 in total

1.  Greater trochanter morphology and association with patient demographics, surgical factors, and post-operative stem position: a retrospective assessment of 150 cementless THRs in 135 dogs.

Authors:  Catrina J Silveira; Katherine H Barnes; Sharon C Kerwin; W Brian Saunders
Journal:  BMC Vet Res       Date:  2022-02-23       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.